January 4, 2018 / 1:12 PM / Updated 10 minutes ago BRIEF-Cellect Biotechnology Announces Clinical Results Reuters Staff 1 Min Read 
Jan 4 (Reuters) - Cellect Biotechnology Ltd: 
* CELLECT BIOTECHNOLOGY - ‍COMPLETED TRANSPLANTATION OF FIRST GROUP OF 3 PATIENTS USING CELLECT‘S APOGRAFT TECHNOLOGY IN CO‘S PHASE I/II CLINICAL TRIAL​ 
* CELLECT BIOTECHNOLOGY-‍AFTER 1 MONTH FOLLOW-UP, ALL 3 PATIENTS DEMONSTRATED ACCEPTANCE OF STEM CELL TRANSPLANT WITH NO ADVERSE EVENTS RELATED TO STUDY​ Source text for Eikon: Further company coverage: